A detailed history of Stifel Financial Corp transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Stifel Financial Corp holds 37,475 shares of SNDX stock, worth $488,673. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,475
Previous 16,976 120.75%
Holding current value
$488,673
Previous $326,000 51.84%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$12.52 - $21.81 $256,647 - $447,083
20,499 Added 120.75%
37,475 $495,000
Q3 2024

Nov 14, 2024

BUY
$17.93 - $24.81 $304,379 - $421,174
16,976 New
16,976 $326,000

Others Institutions Holding SNDX

About Syndax Pharmaceuticals Inc


  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $738M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.